| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -7.28M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TVRD returned -93.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -57.7% |
| 1 year | -93.5% |
| 5 years | -99.7% |
| 10 years | -99.1% |
| All-time high | $935.28 (Nov 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TVRD would be worth today ›No. Tvardi Therapeutics, Inc. has not paid a dividend in the past 12 months.
Tvardi Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TVRD.
Tvardi Therapeutics, Inc. is part of the Healthcare sector.
Tvardi Therapeutics, Inc. has a market cap of 24.28M USD, based on the latest quote.
Tvardi Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
